Delighted to share our work developing an mRNA vaccine for C. difficile, published today in @ScienceMagazine. This study with @WeissmanLab was co-led by two truly amazing scientists: @_alexafluor from the Zackular lab and @MgAlameh (now at @CHOP_Research)! https://t.co/jHXMgQMpc6
I’m proud to share our recent publication describing the development of a multivalent mRNA-LNP vaccine for C. difficile that incorporates targets across C. diff’s complex life cycle https://t.co/cQuur0iWps
Congratulations to former graduate student in the lab, @Brokaryote, on starting a new position in Vaccines & Immune Therapies at @AstraZeneca!! Excited to see the big things coming from the team at AZ! #proudPI
Thrilled to have this story out in @mbiojournal and start to answer the question of how enterococci thrive in the CDI gut with an amazing group of collaborators! Spoiler: it uses heme!
Excited to share the latest from @Brokaryote out in @mbiojournal today!! Alex shows how Enterococci take advantage of C. diff toxin-mediated damage to thrive in the gut. Fun collaborative study with @DariaVanTyne@PrenticeLabUF@Ahmed_Microbes and team! https://t.co/aQ4EzlhWbe
Hello Science Twitter! Really excited to share a short tweetorial of some of my work as a grad student in the @joeyzacks lab at Penn/CHOP focused on the impact of NSAIDs during C. difficile infection: https://t.co/sIU6tGVwvh
Well, twitter friends, it's official: I'm staying in academia and in Philly, starting as a #newPI on the tenure track in @PennMedicine's Department of Medicine, Division of Translational #Medicine and Human #Genetics 😃🍾🧬
To start, I want to share one of the coolest papers to come out in nature in years (I might be biased...) from microbiology student @Brokaryote from @joeyzacks lab! A terrific demonstration of top notch microbial pathogenesis and genomics research at Penn 🎉
Helping C. difficile to thrive
This study reports that Enterococcus species can remodel the metabolic environment in the gut and reprogramme the metabolism of Clostridioides difficile, enhancing its fitness and virulence.
https://t.co/w05mYWk0hG
Gearing up to offer our DIYtranscriptomics course again this Spring semester (Jan), covering bulk and #singlecell RNA-seq. All video lectures will be freely available online. Updated labs too! Something specific you'd like to see? Post in the comments!
https://t.co/iDxjDdiaIY
▶️ Cephalosporin use is a risk factor for C difficile
▶️ Cephalosporins don't kill enterococci
▶️ Enterococci support growth of C difficile (this is the ⭐new⭐ data @Nature 👇) #microbiome#antimicrobialstewardship
https://t.co/zpvnrYuAfk
Thrilled to share my work from the @joeyzacks lab published today in @nature. We find that enterococci enhance C. difficile fitness and virulence by remodeling the metabolic environment in the gut. Thread below with highlights. https://t.co/Bl7HYgLOJj